Hye Won Jeon

Hye Won Jeon

Auto-generated profile, based on publicly available information

Hye Won Jeon

College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Immune Network
Verified
Journal Article
Open access
HKHyung Sook Kim
Hyung Sook Kim
JLJae Seob Lee
Jae Seob Lee
HLHong Kyung Lee
Hong Kyung Lee
EPEun Jae Park
Eun Jae Park
HJHye Won Jeon
Hye Won Jeon
Sang-Bae HanSang-Bae Han
Sang-Bae Han
Mesenchymal stem cells (MSCs) ameliorate the renal injury in Adriamycin (ADR)-induced nephropathy, but the mechanisms underlying their efficacy remain incompletely understood. In this study, we demonstrated that MSCs increased the survival, recovered body weight loss, and decreased proteinuria and serum creatinine levels in ADR-treated mice. MSCs also prevented podocyte damage and renal fibrosis by decreasing the expression of fibronectin, collagen 1α1, and α-smooth muscle actin. From a mechanistic perspective, MSCs inhibited renal inflammation by lowering the expression of CCL4, CCL7, CCL19, IFN-α/β, TGF-β, TNF-α, and chitinase 3-like 1. In summary, our data demonstrate that MSCs improve renal functions by inhibiting renal inflammation in ADR-induced nephropathy.